Early and Sustained Efficacy of Fremanezumab over 24-Weeks in Migraine Patients with Multiple Preventive Treatment Failures: the Multicenter, Prospective, Real-Life FRIEND2 Study.
JOURNAL OF HEADACHE AND PAIN(2023)
Key words
Fremanezumab,Migraine treatment,CGRP monoclonal antibody,Real-world,Long-term treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined